Design of a randomized controlled trial to assess the comparative effectiveness of a multifaceted intervention to improve adherence to colorectal cancer screening among patients cared for in a community health center

BMC Health Services Research

Volumn 13, Issue 1, 2013, Pages

  Baker, David W ^a   Brown, Tiffany ^a   Buchanan, David R ^b   Weil, Jordan ^b   Cameron, Kenzie A ^a   Ranalli, Lauren ^b   Ferreira, M Rosario ^a   Stephens, Quinn ^a   Balsley, Kate ^b   Goldman, Shira N ^a   Wolf, Michael S ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Erie Family Health Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; EARLY DIAGNOSIS; HEALTH CENTER; HUMAN; METHODOLOGY; MIDDLE AGED; OCCULT BLOOD; ORGANIZATION AND MANAGEMENT; PATIENT COMPLIANCE; PATIENT EDUCATION; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; STATISTICS AND NUMERICAL DATA;

AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; COMMUNITY HEALTH CENTERS; COMPARATIVE EFFECTIVENESS RESEARCH; EARLY DETECTION OF CANCER; HUMANS; MIDDLE AGED; OCCULT BLOOD; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; RESEARCH DESIGN;

EID: 84876800400     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-13-153     Document Type: Article

References (52)

1. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Whitlock EP, Lin JS, Liles E, Beil TL, Fu R, Ann Intern Med 2008 149 9 638 658 10.7326/0003-4819-149-9-200811040- 00245 18838718
2. A national survey of primary care physicians' colorectal cancer screening recommendations and practices. Klabunde CN, Frame PS, Meadow A, Jones E, Nadel M, Vernon SW, Prev Med 2003 36 3 352 362 10.1016/S0091-7435(02)00066-X 12634026 (Pubitemid 36299087)
3. Use of colorectal cancer tests-United States, 2002, 2004, and 2006. Centers for Disease Control and Prevention (CDC), MMWR Morb Mortal Wkly Rep 2008 57 10 253 258 18340331
4. Racial and ethnic disparities in cancer screening: the importance of foreign birth as a barrier to care. Goel MS, Wee CC, McCarthy EP, Davis RB, Ngo-Metzger Q, Phillips RS, J Gen Intern Med 2003 18 12 1028 1035 10.1111/j.1525-1497.2003.20807.x 14687262 (Pubitemid 38091398)
5. Systematic review: enhancing the use and quality of colorectal cancer screening. Holden DJ, Jonas DE, Porterfield DS, Reuland D, Harris R, Ann Intern Med 2010 152 10 668 676 10.7326/0003-4819-152-10-201005180-00239 20388703
6. Patterns of colorectal cancer screening uptake among men and women in the United States. Meissner HI, Breen N, Klabunde CN, Vernon SW, Cancer Epidemiol Biomarkers Prev 2006 15 2 389 394 10.1158/1055-9965.EPI-05-0678 16492934 (Pubitemid 43342192)
7. Disparities in colon cancer screening in the Medicare population. Ananthakrishnan AN, Schellhase KG, Sparapani RA, Laud PW, Neuner JM, Arch Intern Med 2007 167 3 258 264 10.1001/archinte.167.3.258 17296881
8. Colorectal cancer test use among Hispanic and non-Hispanic U.S. populations. Pollack LA, Blackman DK, Wilson KM, Seeff LC, Nadel MR, Prev Chronic Dis 2006 3 2 50 16539791
9. Factors associated with Hispanic/non-Hispanic white colorectal cancer screening disparities. Jerant AF, Arellanes RE, Franks P, J Gen Intern Med 2008 23 8 1241 1245 10.1007/s11606-008-0666-1 18500503
10. Effect of area poverty rate on cancer screening across US communities. Schootman M, Jeffe DB, Baker EA, Walker MS, J Epidemiol Community Health 2006 60 3 202 207 10.1136/jech.2005.041020 16476748 (Pubitemid 43288624)
11. Longitudinal adherence with fecal occult blood test screening in community practice. Fenton JJ, Elmore JG, Buist DS, Reid RJ, Tancredi DJ, Baldwin LM, Ann Fam Med 2010 8 5 397 401 10.1370/afm.1133 20843880
12. Longitudinal adherence to fecal occult blood testing impacts colorectal cancer screening quality. Gellad ZF, Stechuchak KM, Fisher DA, Olsen MK, McDuffie JR, Ostbye T, Yancy WS Jr, Am J Gastroenterol 2011 106 6 1125 1134 10.1038/ajg.2011.11 21304501
13. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Pignone M, Saha S, Hoerger T, Mandelblatt J, Ann Intern Med 2002 137 2 96 104 10.7326/0003-4819-137-2- 200207160-00007 12118964 (Pubitemid 34779153)
14. Patient outreach to promote colorectal cancer screening among patients with an expired order for colonoscopy: a randomized controlled trial. Cameron KA, Persell SD, Brown T, Thompson J, Baker DW, Arch Intern Med 2011 171 7 642 646 10.1001/archinternmed.2010.468 21149742
15. The Preferred Screening Method For Patients [ http://www.polymedco.com/ product-overview-pages-61.php ]
16. A multicenter prospective study of immunochemical fecal occult blood testing for colorectal cancer detection. Lohsiriwat V, Thavichaigarn P, Awapittaya B, J Med Assoc Thai 2007 90 11 2291 2295 18181309 (Pubitemid 350256427)
17. Randomized controlled trial of the impact of intensive patient education on compliance with fecal occult blood testing. Stokamer CL, Tenner CT, Chaudhuri J, Vazquez E, Bini EJ, J Gen Intern Med 2005 20 3 278 282 10.1111/j.1525-1497. 2005.40023.x 15836533 (Pubitemid 40628733)
18. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, Verbeek AL, Jansen JB, Dekker E, Gastroenterology 2008 135 1 82 90 10.1053/j.gastro.2008.03.040 18482589 (Pubitemid 351899018)
19. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Hol L, van Leerdam ME, van Ballegooijen M, van Vuuren AJ, van Dekken H, Reijerink JC, van der Togt AC, Habbema JD, Kuipers EJ, Gut 2010 59 1 62 68 10.1136/gut.2009.177089 19671542
20. Meta-analysis: adherence to colorectal cancer screening and the detection rate for advanced neoplasia, according to the type of screening test. Hassan C, Giorgi Rossi P, Camilloni L, Rex DK, Jimenez-Cendales B, Ferroni E, Borgia P, Zullo A, Guasticchi G, Group H, Aliment Pharmacol Ther 2012 36 10 929 940 10.1111/apt.12071 23035890
21. Improving hypertension quality measurement using electronic health records. Persell SD, Kho AN, Thompson JA, Baker DW, Med Care 2009 47 4 388 394 10.1097/MLR.0b013e31818b070c 19330887
22. Cialdini RB, Influence: Science and practice, vol. 4 Allyn and Bacon: Boston, MA 2001
23. Festinger L, A Theory of Cognitive Dissonance Stanford, California: Stanford University Press 1957
24. Diagnostic testing following fecal occult blood screening in the elderly. Lurie JD, Welch HG, J Natl Cancer Inst 1999 91 19 1641 1646 10.1093/jnci/91.19.1641 10511591 (Pubitemid 29479931)
25. Barriers to full colon evaluation for a positive fecal occult blood test. Fisher DA, Jeffreys A, Coffman CJ, Fasanella K, Cancer Epidemiol Biomarkers Prev 2006 15 6 1232 1235 10.1158/1055-9965.EPI-05-0916 16775188
26. Challenges in the management of positive fecal occult blood tests. Rao SK, Schilling TF, Sequist TD, J Gen Intern Med 2009 24 3 356 360 10.1007/s11606-008-0893-5 19130147
27. Screening for colorectal cancer. A comparison of 3 fecal occult blood tests. Levin B, Hess K, Johnson C, Arch Intern Med 1997 157 9 970 976 10.1001/archinte.1997.00440300064005 9140267 (Pubitemid 27190884)
28. Improvement in the diagnostic evaluation of a positive fecal occult blood test in an integrated health care organization. Miglioretti DL, Rutter CM, Bradford SC, Zauber AG, Kessler LG, Feuer EJ, Grossman DC, Med Care 2008 46 9 Suppl 1 91 S96 18725839
29. Measuring the quality of colorectal cancer screening: the importance of follow-up. Etzioni DA, Yano EM, Rubenstein LV, Lee ML, Ko CY, Brook RH, Parkerton PH, Asch SM, Dis Colon Rectum 2006 49 7 1002 1010 10.1007/s10350-006- 0533-2 16673056 (Pubitemid 44060854)
30. Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result. Baig N, Myers RE, Turner BJ, Grana J, Rothermel T, Schlackman N, Weinberg DS, Am J Gastroenterol 2003 98 9 2078 2081 10.1111/j.1572-0241.2003.07575.x 14499791 (Pubitemid 37185809)
31. Factors that influence the decision to do an adequate evaluation of a patient with a positive stool for occult blood. Shields HM, Weiner MS, Henry DR, Lloyd JA, Ransil BJ, Lamphier DA, Gallagher DW, Antonioli DA, Rosner BA, Am J Gastroenterol 2001 96 1 196 203 10.1111/j.1572-0241.2001.03475.x 11197252 (Pubitemid 32104828)
32. Physician and patient factors associated with ordering a colon evaluation after a positive fecal occult blood test. Turner B, Myers RE, Hyslop T, Hauck WW, Weinberg D, Brigham T, Grana J, Rothermel T, Schlackman N, J Gen Intern Med 2003 18 5 357 363 10.1046/j.1525-1497.2003.20525.x 12795734 (Pubitemid 36751077)
33. Impact of colonic cleansing on quality and diagnostic yield of colonoscopy: the European panel of appropriateness of gastrointestinal endoscopy European multicenter study. Froehlich F, Wietlisbach V, Gonvers JJ, Burnand B, Vader JP, Gastrointest Endosc 2005 61 3 378 384 10.1016/S0016-5107(04)02776-2 15758907 (Pubitemid 40349029)
34. Impact of colonoscopy preparation quality on detection of suspected colonic neoplasia. Harewood GC, Sharma VK, de Garmo P, Gastrointest Endosc 2003 58 1 76 79 10.1067/mge.2003.294 12838225 (Pubitemid 38208751)
35. Screening for colorectal neoplasia: physicians' adherence to complete diagnostic evaluation. Myers RE, Balshem AM, Wolf TA, Ross EA, Millner L, Am J Public Health 1993 83 11 1620 1622 10.2105/AJPH.83.11.1620 8238690 (Pubitemid 23320051)
36. Impact of a physician-oriented intervention on follow-up in colorectal cancer screening. Myers RE, Turner B, Weinberg D, Hyslop T, Hauck WW, Brigham T, Rothermel T, Grana J, Schlackman N, Prev Med 2004 38 4 375 381 10.1016/j.ypmed.2003.11.010 15020170 (Pubitemid 38327009)
37. Colorectal cancer screening, comorbidity, and follow-up in elderly patients. Garman KS, Jeffreys A, Coffman C, Fisher DA, Am J Med Sci 2006 332 4 159 163 10.1097/00000441-200610000-00001 17031239 (Pubitemid 44563800)
38. Fecal occult blood testing in a general medical clinic: comparison between guaiac-based and immunochemical-based tests. Ko CW, Dominitz JA, Nguyen TD, Am J Med 2003 115 2 111 114 10.1016/S0002-9343(03)00294-8 12893396 (Pubitemid 37288838)
39. Automated telephone calls improved completion of fecal occult blood testing. Mosen DM, Feldstein AC, Perrin N, Rosales AG, Smith DH, Liles EG, Schneider JL, Lafata JE, Myers RE, Kositch M, Med Care 2010 48 7 604 610 10.1097/MLR.0b013e3181dbdce7 20508529
40. Screening for colorectal cancer by nurse endoscopists. Maule WF, N Engl J Med 1994 330 3 183 187 10.1056/NEJM199401203300307 8264742 (Pubitemid 24026888)
41. Screening for colorectal cancer with flexible sigmoidoscopy by nonphysician endoscopists. Wallace MB, Kemp JA, Meyer F, Horton K, Reffel A, Christiansen CL, Farraye FA, Am J Med 1999 107 3 214 218 10.1016/S0002-9343(99) 00225-9 10492313 (Pubitemid 29421586)
42. Effectiveness and patient satisfaction with screening flexible sigmoidoscopy performed by registered nurses. Schoenfeld PS, Cash B, Kita J, Piorkowski M, Cruess D, Ransohoff D, Gastrointest Endosc 1999 49 2 158 162 10.1016/S0016-5107(99)70480-3 9925692 (Pubitemid 29111307)
43. Physicians' use of nonphysician healthcare providers for colorectal cancer screening. Sansbury LB, Klabunde CN, Mysliwiec P, Brown ML, Am J Prev Med 2003 25 3 179 186 10.1016/S0749-3797(03)00203-4 14507523 (Pubitemid 41116518)
44. A multimedia patient education program on colorectal cancer screening increases knowledge and willingness to consider screening among Hispanic/Latino patients. Makoul G, Cameron KA, Baker DW, Francis L, Scholtens D, Wolf MS, Patient Educ Couns 2009 76 2 220 226 10.1016/j.pec.2009.01.006 19250791
45. Investigating Hispanic/Latino perceptions about colorectal cancer screening: a community-based approach to effective message design. Cameron KA, Francis L, Wolf MS, Baker DW, Makoul G, Patient Educ Couns 2007 68 2 145 152 10.1016/j.pec.2007.04.004 17517486 (Pubitemid 47375021)
46. Preferences for colorectal cancer screening among racially/ethnically diverse primary care patients. Hawley ST, Volk RJ, Krishnamurthy P, Jibaja-Weiss M, Vernon SW, Kneuper S, Med Care 2008 46 9 Suppl 1 10 S16 18725820
47. Colorectal cancer screening preferences among African Americans: which screening test is preferred? Palmer RC, Midgette LA, Mullan ID, J Cancer Educ 2010 25 4 577 581 10.1007/s13187-010-0081-2 20229075
48. Cancer and colorectal cancer: knowledge, beliefs, and screening preferences of a diverse patient population. Shokar NK, Vernon SW, Weller SC, Fam Med 2005 37 5 341 347 15883900 (Pubitemid 40656182)
49. Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening. DeBourcy AC, Lichtenberger S, Felton S, Butterfield KT, Ahnen DJ, Denberg TD, J Gen Intern Med 2008 23 2 169 174 10.1007/s11606-007-0480-1 18157581
50. Patient preferences and adherence to colorectal cancer screening in an urban population. Wolf RL, Basch CE, Brouse CH, Shmukler C, Shea S, Am J Public Health 2006 96 5 809 811 10.2105/AJPH.2004.049684 16571715
51. A program to enhance completion of screening colonoscopy among urban minorities. Chen LA, Santos S, Jandorf L, Christie J, Castillo A, Winkel G, Itzkowitz S, Clin Gastroenterol Hepatol 2008 6 4 443 450 10.1016/j.cgh.2007.12. 009 18304882
52. Preferences for colorectal cancer screening tests and screening test use in a large multispecialty primary care practice. Hawley ST, McQueen A, Bartholomew LK, Greisinger AJ, Coan SP, Myers R, Vernon SW, Cancer 2012 118 10 2726 2734 10.1002/cncr.26551 21948225